Neuromyelitis optica (NMOSD): open trials in Italy

• NCT05966467

  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  Research · Alexion Pharmaceuticals, Inc.

  Naples

  Registry updated 2026-10-13

• NCT05199688

  A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Fondazione Istituto Neurologico Nazionale Casimiro Mondino, Pavia · Ospedale Pediatrico Bambino Gesù, Rome

  Registry updated 2026-10-01

• 2025-522821-37-00

  Basket trial for B-cEll driven severe auToimmunE and aLoimmune diseases (chronic Graft vErsUs host diseaSe) treated with anti-CD19 CAR T-cell thErapy

  Trial Treatment · Phase 1 · Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico

  Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico, Bologna · Ospedale Pediatrico Bambino Gesù, Rome

  Registry updated 2026-09-29

All Neuromyelitis optica (NMOSD) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error